Clinical Trial Update: Implementation of Pre-emptive Geno- and Phenotyping in 5-Fluorouracil- or Capecitabine-treated Patients [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating pre-emptive geno- and phenotyping in patients treated with 5-fluorouracil or capecitabine for various GI cancers.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anal Cancer
• Colon Cancer
• Esophageal Cancer
• Pancreatic Cancer
• Stomach Cancer

Snippet

Sponsor: Jessa Hospital | Conditions: Colon Cancer, Stomach Tumor | Phase 4 | Status: UNKNOWN